Skip to main content
Clinical Trials/PACTR201601001416338
PACTR201601001416338Other未知

Efficacy of single vs. multiple Praziquantel MDA against Schistosoma mansoni infections among primary school children

elson Mandela African Institution of science and Technology-Arusha0 sites513 target enrollmentStarted: January 9, 2016Last updated:

Trial Snapshot

Phase
未知
Status
Other
Sponsor
Enrollment
513

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
6 Year(s) to 16 Year(s) (—)
Sex
All

Inclusion Criteria

  • School children between 6 - 19 years of age
  • Children agree to participate in the study
  • Parents give a written informed consent

Exclusion Criteria

  • History of being clinically ill and used drug within a period of two weeks before the study
  • Refusal of parents to sign a written informed consent
  • Evidence of being sick during the time of recruitment

Investigators

Sponsor
elson Mandela African Institution of science and Technology-Arusha

Similar Trials